Interim Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current Assets
Cash and cash equivalents	$ 5,028	$ 7,926
Restricted cash-funds held in trust		467,798
Trade receivables	234,677	121,276
Government remittances receivable	7,267	38,578
Other receivables		20,624
Inventory		5,389
Prepaid expenses and deposits	36,625	46,028
Total Current Assets	283,597	707,619
Intangible Assets	255,322	237,271
Long-lived Assets, net	4,783,055	4,762,453
Long-Term Assets	5,038,377	4,999,724
Total Assets	5,321,974	5,707,343
Current Liabilities
Accounts payable	1,187,497	958,313
Government remittances payable	167,137	35,187
Accrued liabilities	741,996	487,592
Advance	61,805	3,255
Deferred revenue	4,573	9,239
Current portion of long-term debt	5,594,538	5,793,677
Current portion of obligations under capital lease	409,660	218,069
Convertible promissory notes	1,520,433	1,406,029
Loans payable to related party	48,731
Total Current Liabilities	9,736,370	8,911,361
Long-term debt	59,976	0
Total Long-term Liabilities	59,976
Total Liabilities	9,796,346	8,911,361
Stockholders' Deficiency
Preferred stock, $.0001 par value, 10,000,000 authorized, none issued and outstanding
Common stock, $.0001 par value, 150,000,000 authorized, 79,372,643 (2019- 51,784,504) shares issued and outstanding	7,940	5,180
Additional paid-in capital	8,628,336	7,450,091
Stock compensation reserve		1,000,000
Accumulated deficit	(12,963,987)	(11,449,497)
Accumulated other comprehensive loss	(146,661)	(209,792)
Stockholders' deficiency	(4,474,372)	(3,204,018)
Total Liabilities and Stockholders' Deficiency	$ 5,321,974	$ 5,707,343